Heiko D. S.
- Country
- Belgium
- Department
- University Hospital Antwerp
Research Overview
- Multicenter randomized controlled clinical trial comparing ebastine and mebeverine as treatment of irritable bowel syndrome
- Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study of Brenipatide (LY3537031) for Efficacy and Safety in Adults with Irritable Bowel Syndrome‑Constipation
- Efficacy of Citalopram in Patients with Reflux Hypersensitivity or Functional Heartburn Unresponsive to Proton Pump Inhibitors: A Placebo-Controlled Study
Data & Insights
Has run more than one trial at 17 of 119 partner sites.
Specializations
Esophageal Disorders
The investigator specializes in treating complex eosinophilic esophagitis (EoE), focusing on immune-mediated inflammatory responses in the esophagus and their clinical manifestations.
- Chronic inflammatory disorders
- Esophageal dysfunction
- Immune response mechanisms
Research activities explore novel therapeutic approaches for managing esophageal inflammation and dysfunction.
Gastroesophageal Reflux Disease
Expertise centers on managing refractory GERD and related conditions, with particular attention to patients who show incomplete response to conventional treatments.
- Treatment-resistant reflux
- Functional heartburn
- Reflux hypersensitivity
The investigator explores innovative therapeutic combinations for optimizing patient outcomes in resistant cases.
Gastrointestinal Motility
Focus includes the investigation of gastroparesis, particularly addressing delayed gastric emptying in both idiopathic and diabetic conditions.
- Diabetic gastroparesis
- Idiopathic gastroparesis
- Gastric motility disorders
Research encompasses evaluation of novel therapeutic agents for improving gastric motility and symptom management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.